Poop pills and fiber: a new hope for constipation?

NCT ID NCT07387952

Recruiting now Disease control Sponsor: Peking Union Medical College Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether a fecal microbiota transplant (FMT) combined with a high-fiber diet can safely and effectively treat chronic constipation. Five adults with functional constipation will receive FMT via colonoscopy and take a dietary fiber supplement. Researchers will track bowel movements, stool consistency, and side effects to see if this approach works better than standard laxatives.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fecal microbiota transplant (FMT) and high dietary fiber preparation
What this could lead to: If it works, this could point toward a new treatment for chronic constipation that doesn't rely on laxatives.
What could go wrong: This is a very small pilot study with only 5 participants, so results may not apply to everyone. The procedure involves colonoscopy and a colostomy, which carries risks like infection or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

constipation disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC CONSTIPATION CONSTIPATION - FUNCTIONAL FECAL MICROBIOTA TRANSPLANTATION (FMT)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Peking Union Medical College Hospital
RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.